全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
重要通知:仅供研究使用。我们不向患者销售。
Discription | MK-4827 is a novel potent, orally bioavailable PARP-1 and PARP-2 inhibitor. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A11026 |
---|---|
分子式 | C19H20N4O |
分子量 | 320.4 |
CAS号 | 1038915-60-4 |
SMILES | C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N |
其他名称 | MK4827 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 60 mg/mL (187.27 mM) | |
Water | Insoluble | ||
Ethanol | 60 mg/mL (187.27 mM) | ||
In vivo | 10% DMSO+40% PEG 300+5% Tween 80+ddH2O | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 31.21 mL | 156.05 mL | 312.11 mL |
0.5 mM | 6.24 mL | 31.21 mL | 62.42 mL |
1 mM | 3.12 mL | 15.61 mL | 31.21 mL |
5 mM | 0.62 mL | 3.12 mL | 6.24 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2